This study evaluates the efficacy of the thyroid hormone T3 for depression in patients with
bipolar disorder. In this study patients will be randomized to receive T3 or placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Northwell Health
Collaborator:
National Alliance for Research on Schizophrenia and Depression